Transfer of Material. Within thirty (30) days following the Effective Date, BRIDGE shall transfer to ALGORX, or its designee, all available GMP-quality quantities of ****** and ****** in its possession and in the possession of the manufacturer of the GMP-material without further consideration by ALGORX; provided, however, that BRIDGE shall be permitted to retain such quantities of the Compound as is necessary to allow BRIDGE to discharge its obligations hereunder. ALGORX will acknowledge receipt in writing.
Appears in 3 contracts
Sources: Collaboration, Development and License Agreement (Algorx Pharmaceuticals Inc), Collaboration, Development and License Agreement (Algorx Pharmaceuticals Inc), Collaboration, Development and License Agreement (Algorx Pharmaceuticals Inc)